++
For further information, see CMDT Part 28-24: Primary Aldosteronism
+++
Essentials of Diagnosis
++
Hypertension may be severe or drug-resistant
Hypokalemia (in minority of patients) may cause polyuria, polydipsia, muscle weakness
Low plasma renin; elevated plasma and urine aldosterone levels
+++
General Considerations
++
Refers to renin-independent, inappropriately high and non-suppressible aldosterone secretion
Excessive aldosterone production
Although most affected patients have hypertension, some may be normotensive
Cardiovascular events are more prevalent in patients with aldosteronism (35%) than in those with essential hypertension (11%)
May be caused by a unilateral aldosterone-producing adrenal cortical adenoma (Conn syndrome, 25%)
More commonly caused by adrenal cortical hyperplasia (75%)
Bilateral aldosteronism may be corticosteroid suppressible due to an autosomal-dominant genetic defect allowing adrenocorticotropic hormone stimulation of aldosterone production
Malignant ovarian tumors are rare cause of hyperaldosteronism
++
The prevalence of primary aldosteronism is 5–10% in hypertensive patients and at least 20% in patients with resistant hypertension
Should also be suspected with early-onset hypertension or stroke before age 50 years
Patients of all ages may be affected, but the peak incidence is between 30 and 60 years
++
Hypertension is typically moderate but may be severe
Some patients have only diastolic hypertension, without other symptoms and signs
Edema (rare)
Muscle weakness (at times with paralysis simulating periodic paralysis), paresthesias with tetany, headache, polyuria, and polydipsia may be seen in patients with hypokalemia
+++
Differential Diagnosis
++
Essential hypertension
Primary aldosteronism and cases of low renin essential hypertension may overlap, making distinguishing between them difficult
Hypokalemia due to other cause (eg, diuretics)
Apparent mineralocorticoid excess syndrome caused by real licorice or anise-flavored drinks
Hypertension and hypokalemia caused by medications (eg, abiraterone, posaconazole)
Increased aldosterone secretion due to oral contraceptive use
Renal vascular hypertension (hypertension and hypokalemia, but high plasma renin activity [PRA])
Secondary hyperaldosteronism (dehydration, heart failure)
Congenital adrenal hyperplasia: 11β-hydroxylase deficiency, 17α-hydroxylase deficiency
Cushing syndrome
Primary cortisol resistance
Liddle syndrome
++
Plasma potassium should be determined in hypertensive individuals; however, hypokalemia is present in only 37% of affected patients: 50% of those with an aldosterone-producing adenoma and 17% of those with adrenal hyperplasia
An elevated serum bicarbonate (HCO3) concentration indicates metabolic alkalosis and is commonly present
Testing for primary aldosteronism should be done for all hypertensive patients with any of the following: